Acute Promyelocytic Leukemia - 35 Studies Found

Terminated : Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
: Acute Promyelocytic Leukemia
: 2009-09-25
:
  • Drug: Tamibarotene Self-admini
Completed : French Registry of First-line Treatment of Acute Promyelocytic Leukemia
: Acute Promyelocytic Leukemia
: 2016-09-22
Completed : Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia
: Acute Promyelocytic Leukemia
: 2013-03-28
: Other: Health Related Quality of Life (HRQOL) measures Other Names:
  • SF-
Withdrawn : New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia
: Acute Promyelocytic Leukemia
: 2008-04-28
:
  • Drug: NRX 195183 (retinoid analogue)

Active, not recruiting : Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
: Acute Promyelocytic Leukemia
: 2011-07-27
: Drug: Tretinoin and Arsenic Trioxide See Detailed Description
Completed : Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
: Acute Promyelocytic Leukemia
: 2007-07-19
:
  • Drug: Arsenic Trioxide

Completed : AIDA 2000 Guidelines
: Acute Promyelocytic Leukemia
: 2010-02-05
: Drug: all-trans retinoic acid (ATRA)
Completed : Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
: Acute Promyelocytic Leukemia
: 2012-12-06
:
  • Drug: ATRA+arsenic experimenta
Completed : All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
: Acute Promyelocytic Leukemia
: 2006-12-15
:
  • Drug: All-Trans Retinoic Acid (ATRA)

Completed : Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
:
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Untreated Childhood
    : 2009-03-20
    :
    • Drug: arsenic trioxide Given I
<<< Previous | Next >>>